Respiratory tract infections (RTIs) are the most common, and potentially most severe, of infections treated by health care practitioners. Lower RTIs along with influenza, are the most common cause of death by infection in the United States. Identifying the causative pathogen(s) rapidly and accurately is key in deciding on a proper treatment protocol. American Medical Lab Solutions is now offering a new solution to pathogen detection in RTIs, Real-Time Polymerase Chain Reaction for Respiratory Tract Microbiota (qPCR).
American Medical Lab Solutions will only employ labs that are using the latest molecular biology techniques, is able to use the genetic material of the pathogen (DNA, RNA) to accurately identify the species of the pathogen and to detect resistance genes expressed by the pathogen to certain pharmacotherapies.